http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111803499-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111803499-B |
| titleOfInvention | Medicine composition II for treating gout and hyperuricemia |
| abstract | The invention discloses a pharmaceutical composition II for treating gout and hyperuricemia, which has a general structure shown in formula II. The application of a series of compounds with xanthine oxidase inhibitory activity in the preparation of anti-gout and anti-hyperuricemia drugs provided by the invention is proved by in vitro enzyme activity experiments to have obvious Xanthine Oxidase (XO) inhibitory effect. |
| priorityDate | 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.